| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Former 10% Owner
6 companies
Boxer Capital, LLC last filed a Form 4 in February 2024, as 10% Owner at TNGX. The filings on record cover 6 companies. From June 2016 to February 2024, the filings on record show 7 open-market purchases and 4 sales.
Our model assigns Boxer Capital, LLC a strong insider score of 79/100, based on 12 past trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +39.4%.
At the last filing, the largest reported position was 8,198,642 shares of TNGX. Net of sales, the TNGX filings show accumulation of 1,919,000 shares.
Shares as reported in the last Form 4 for each company; the most recent is from February 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2016 | CARM Carisma Therapeutics Inc. | 10% Owner | Sell | 1,042,000 | $2.74 | $2,859,352.20 | -77.8% |